FcγRIIB inhibits inflammation in a murine model of psoriasis

I Nakabori, Y Hamaguchi, K Sawada, M Horii… - Journal of …, 2022 - Elsevier
Background Psoriasis is a chronic, inflammatory cutaneous disease. FcγRIIB is a low-affinity
receptor for the IgG Fc fragment that provides a negative feedback pathway to down …
被引用次数：1 相关文章

[引用][C] FcγRIIB inhibits inflammation in a murine model of psoriasis

I Nakabori, Y Hamaguchi, K Sawada, M Horii… - Journal of …, 2022 - cir.nii.ac.jp
FcγRIIB inhibits inflammation in a murine model of psoriasis | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

FcγRIIB inhibits inflammation in a murine model of psoriasis

I Nakabori, Y Hamaguchi, K Sawada… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Psoriasis is a chronic, inflammatory cutaneous disease. FcγRIIB is a low-affinity
receptor for the IgG Fc fragment that provides a negative feedback pathway to down …

FcγRIIB inhibits inflammation in a murine model of psoriasis.

I Nakabori, Y Hamaguchi, K Sawada… - Journal of …, 2022 - europepmc.org
Background Psoriasis is a chronic, inflammatory cutaneous disease. FcγRIIB is a low-affinity
receptor for the IgG Fc fragment that provides a negative feedback pathway to down …

FcγRIIB inhibits inflammation in a murine model of psoriasis

I Nakabori, Y Hamaguchi, K Sawada… - Journal of …, 2022 - jdsjournal.com
Background Psoriasis is a chronic, inflammatory cutaneous disease. FcγRIIB is a low-affinity
receptor for the IgG Fc fragment that provides a negative feedback pathway to down …

FcγRIIB inhibits inflammation in a murine model of psoriasis

I Nakabori, Y Hamaguchi, K Sawada… - Journal of …, 2022 - jdsjournal.com
Background Psoriasis is a chronic, inflammatory cutaneous disease. FcγRIIB is a low-affinity
receptor for the IgG Fc fragment that provides a negative feedback pathway to down …